Plus Therapeutics | CYTX - Des Atouts





Des Atouts Changement Date
Baxter International USD 19.79B 55M 2026-06
Cerus USD 221.86M 6.67M 2025-12
Dr.Reddys Laboratories INR 575.31B 5.93B 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Northwest Biotherapeutics USD 80.05M 49.44M 2026-03
Plus Therapeutics USD 14.03M 5.89M 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Starpharma Holdings AUD 26.17M 746K 2025-12
Sun Pharmaceuticals INR 1.09T 50.79B 2026-03
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06